Yurcisin Jeffrey Michael, President & CEO of Groove Botanicals (GROV), has demonstrated a clear selling bias in his recent insider transactions, with $94,945.80 in total sales compared to $30,239.25 in purchases across 24 reported trades. His activity has been exclusively concentrated in GROV, with no transactions in other companies. The most recent sales occurred on February 15, 2026, totaling $31,403.20 across three separate filings, following earlier disposals on November 17, 2025 ($39,164.70) and August 15, 2025 ($24,778.70). These sales were all coded as "F" transactions, indicating they were discretionary trades rather than mandatory exercises.
Prior to this selling pattern, Yurcisin had made three open market purchases in March 2024, acquiring shares worth $10,001.10 on March 11 and $20,238.15 across two transactions on March 8. The absence of any recent purchases—with all buying activity occurring more than two years before the sales—suggests a shift in his position. Notably, the sales have been executed in multiple tranches rather than single large disposals, with individual transaction values ranging from $895.23 to $20,480.48. The most recent filing on March 6, 2026, showed an acquisition with no reported dollar value, coded as an "A" transaction, potentially indicating an equity award rather than an open market purchase.
AI-assisted summary